[關(guān)鍵詞]
[摘要]
目的 探討丹芍消炎合劑聯(lián)合靜脈抗生素治療濕熱型亞急性盆腔炎的臨床效果。方法 83 例確診為亞急性盆腔炎患者隨機(jī)分為2 組;對照組41 例,每12 h 靜脈滴注頭孢西丁2 g(頭孢類過敏者改用克林霉素1 g),使用至臨床癥狀、體征改善后的24 h,同時po 強(qiáng)力霉素100 mg,2 次/d,共2 周;治療組42 例,在對照組基礎(chǔ)上po 芍消炎合劑35 mL/次,3次/d,連續(xù)2 周,比較兩組患者的臨床療效與不良反應(yīng)。結(jié)果 治療組的總有效率為97.6%、愈顯率76.1%,靜脈抗生素使用(3.52±0.94)d;對照組總有效率90.24%、愈顯率29.2%,靜脈抗生素使用(4.95±1.18)d,兩組比較差異有統(tǒng)計學(xué)意義(P<0.01);且兩組均未發(fā)生不良反應(yīng)。結(jié)論 丹芍消炎合劑聯(lián)合靜脈抗生素治療亞急性盆腔炎療效確切,能明顯改善患者的臨床癥狀、縮短靜脈抗生素的使用時間,值得臨床推廣應(yīng)用。
[Key word]
[Abstract]
Objective To investigate clinical effect of Danshao Anti-inflammatory Liquid combined with levofloxacin therapy in the treatment of subacute pelvic inflammatory disease. Methods Eighty-three patients with chronic pelvic inflammatory disease were randomly divided into control (n = 41) and treatment (n = 42) groups. The patients in the control group were iv administered with levofloxacin 2 g per 12 h and po administered with levofloxacin 100 mg, 2 time/d, for 14 d. While the patients in the treatment group were po administered with Danshao Anti-inflammatory Liquid, 35 mL/time, 3 time/d. Clinical effects of the two groups were compared. Results After treatment, the treatment group had total effective rate as 97.6%, which was obviously higher than that of the control group (90.24%). The difference between the two groups was statistical significant (P < 0.01). In addition, the using of the combination solution of Danshao Anti-inflammatory Liquid and vein antibiotics could decrease the using period of vein antibiotics. Conclusion Danshao Anti-inflammatory Liquid combined with levofloxacin therapy provides precise effect in treating subacute pelvic inflammatory disease, can remarkably improve clinical symptoms in patients, and it is worthy of promotion and application.
[中圖分類號]
[基金項目]
上海市科學(xué)技術(shù)委員會科研計劃項目課題(12401901904)